Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse

被引：9

作者：

de Haas, V ^{[1
]}

Breunis, WB ^{[1
]}

Verhagen, OJ ^{[1
]}

van den Berg, H ^{[1
]}

van der Schoot, CE ^{[1
]}

机构：

[1] Red Cross Transfus Serv, Dept Immunohematol, Amsterdam, Netherlands

来源：

BLOOD | 2000年 / 96卷 / 04期

关键词：

D O I：

10.1182/blood.V96.4.1619.h8001608h_1619_1620

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1619 / 1620

页数：2

相关论文

共 3 条

[1] Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia
Panzer-Grümayer, ER
Schneider, M
Panzer, S
Fasching, K
Gadner, H
[J]. BLOOD, 2000, 95 (03) : 790 - 794
[2] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
van Dongen, JJM
Seriu, T
Panzer-Grümayer, ER
Biondi, A
Pongers-Willemse, MJ
Corral, L
Stolz, F
Schrappe, M
Masera, G
Kamps, WA
Gadner, H
van Wering, ER
Ludwig, WD
Basso, G
de Bruijn, MAC
Cazzaniga, G
Hettinger, A
van der Does-van den Berg, A
Hop, WCJ
Riehm, H
Bartram, CR
[J]. LANCET, 1998, 352 (9142) : 1731 - 1738
[3] VERHAGEN OJ, IN PRESS APPL GERMLI